引用次数
引用: 63,129
H-指数: 101
I10-指数 : 366
出版物: 915
培美曲塞（Alimta）治疗非小细胞肺癌新进展
吴一龙 , Giorgio , Scagliotti
中国癌症杂志 16 ( 8) 605 -608
2006
In vivo effect of human granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil GM-CSF receptors.
Piacibello W , Sanavio F , Aglietta M , Pozzi E
Leukemia 9 ( 4) 665 -670
4
1995
Evaluation of calcium metabolism and pituitary gonadotropin secretion during treatment with nifedipine
Scagliotti G , Gozzelino G , Gamna G , Isaia Gg
Giornale italiano di cardiologia 11 ( 10) 1445 -1449
1981
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer.
Debruyne C , Scagliotti G , Splinter Ta , Ardizzoni A
Oncology 11 11 -14
8
1997
Etoposide by oral route in the treatment of unresectable non-small cell lung cancer.
Gozzelino F , Pescetti G , Scagliotti G , Lodico D
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 3 ( 5) 324 -326
1
1984
The electrocardiogram and arterial hypertension in primary hyperparathyroidism
Molinatti Gm , Scagliotti G , Gamna G , Pascale C
Minerva Medica 70 ( 14) 959 -964
1979
Combination chemotherapy for non small cell lung cancer stage III M0-1 with cisplatin and vinblastine in a divided-dose schedule.
Gozzelino F , Pescetti G , Scagliotti Gv , D'Apuzzo C
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 5 ( 5) 351 -355
1986
Chemotherapy of non-small cell lung cancer.
Scagliotti Gv , Crinò L
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 52 ( 3) 287
1997
Neo-adjuvant chemotherapy prior to surgery in stage III non-small cell lung cancer.
Ferrari G , Scagliotti Gv , Novello S
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 52 ( 6) 531
1
1997
Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non small cell lung cancer.
Cappia S , Pozzi E , Michelotto F , Kalikatzaros G
Anticancer Research 11 ( 6) 2207 -2210
23
1991
Abstract B31: Single-agent pemetrexed in patients with ALK-positive NSCLC: A retrospective analysis of investigator-reported outcomes
R Salgia , S I. Ou , G Riely , D W. Kim
Clinical Cancer Research 18
2012
Preliminary results of a dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.
L. Crino , A. Gentile , M. Tonato , E. Corgna
Seminars in Oncology 23 ( 6) 80 -83
3
1996
NEW DRUGS FOR NEW CHEMOTHERAPY STANDARDS
G. V. Scagliotti , S. Novello
Lung biology in health and disease 124 657 -678
2
1999
Neuron specific enolase levels in exudative pleural effusions
E. Pozzi , F. Michelotto , E. Gatti , G. V. Scagliotti
Journal of Tumor Marker Oncology 5 ( 4) 373 -377
1990
Efficacité et tolérance de l'alizapride chez des patients atteints de carcinome pulmonaire et traités avec de fortes doses de cisplatine
F. Gozzelino , G. Pescetti , G. V. Scagliotti , C. Alberta
Comptes rendus de thérapeutique et de pharmacologie clinique 4 ( 45) 15 -19
1986
A phase III randomized study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in early-stage non-small cell lung cancer (NSCLC): Follow-up data of Ch.E.S.
G. V. Scagliotti , U. Pastorino , J. F. Vansteenkiste , L. Spaggiari
Journal of Clinical Oncology 26 ( 15) 7508 -7508
25
2008
Pilot study of early repeated 18F-FDG PET during cycle 1 to predict objective response to chemotherapy in advanced non-small cell lung cancer (NSCLC)
U. Ricardi , S. Novello , E. Pelosi , M. Giaj Levra
Journal of Clinical Oncology 26 8003 -8003
2008
Comparison of patient outcomes stratified by histology among pemetrexed (P)-treated patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC) in two phase II trials
G. Peng , R. G. Zinner , Y. Wang , J. Treat
Journal of Clinical Oncology 26 8096 -8096
16
2008
Differential expression of DNA repair machinery genes in normal bronchial tissue and non-small cell lung cancer (NSCLC)
G. Selvaggi , S. Saviozzi , P. Ceppi , M. Volante
Journal of Clinical Oncology 26 22017 -22017
2008
Preliminary results of a multicenter randomized phase II trial of two different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)
M. Rinaldi , S. Novello , I. Bernardini , L. Crinò
Journal of Clinical Oncology 23 7124 -7124
5
2005